STOCK TITAN

Nu-Med Plus (NUMD) director reports no common stock held

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Nu-Med Plus, Inc. (NUMD) reported the initial insider holdings of Fred Tejada, who is a director, officer (SVP and Chief Geologist), and classified as a ten percent owner. The filing lists one holding entry for Common Stock with 0 shares owned directly following the reported date and no buy or sell transactions.

Positive

  • None.

Negative

  • None.
Insider TEJADA FRED
Role SVP and Chief Geologist
Type Security Shares Price Value
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 0 shares (Direct)
Total Common Stock shares following holding entry 0 shares Total shares of Common Stock owned directly after the reported holding entry
Holding entries 1 Number of Common Stock holding entries reported in the filing
Buy transactions 0 Buy transaction count in transaction summary
Sell transactions 0 Sell transaction count in transaction summary
Derivative transactions 0 Derivative transaction count in transaction summary
Form 3 regulatory
"This Form 3 discloses the initial beneficial ownership of Common Stock"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
ten percent owner regulatory
"is_ten_percent_owner: 1 indicates the reporting person is a ten percent owner"
direct_or_indirect regulatory
"direct_or_indirect: "D" indicates direct_or_indirect ownership type is direct"
transactionSummary financial
"transactionSummary shows counts for buy, sell and other transaction types"

FAQ

What does Nu-Med Plus, Inc. (NUMD) disclose in this Form 3?

The Form 3 discloses the initial beneficial ownership of Common Stock by insider Fred Tejada, a director, SVP and Chief Geologist, and ten percent owner of Nu-Med Plus, Inc., showing 0 shares owned directly after the reported date.

Who is the reporting person in Nu-Med Plus (NUMD)'s Form 3?

The reporting person is Fred Tejada, who serves as a director and as an officer with the title SVP and Chief Geologist, and is also identified as a ten percent owner of Nu-Med Plus, Inc.

How many Nu-Med Plus (NUMD) shares does Fred Tejada report owning on this Form 3?

Fred Tejada reports post-filing holdings of 0 shares of Nu-Med Plus, Inc. Common Stock, held on a direct ownership basis, according to the total shares following the reported holding entry.

Does this Nu-Med Plus (NUMD) Form 3 show any insider buy or sell transactions?

No. The filing’s transaction summary shows 0 buy transactions, 0 sell transactions, and a single holding entry for Common Stock, indicating disclosure of holdings rather than a new purchase or sale.

What type of ownership is reported for Fred Tejada’s NUMD Common Stock holdings?

The Form 3 identifies the ownership type as direct for the Common Stock holding entry, with total shares following the transaction reported as 0.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
TEJADA FRED

(Last)(First)(Middle)
C/O NU-MED PLUS, INC.
640 BELLE TERRE BUILDING 2E

(Street)
PORT JEFFERSON11777

(City)(State)(Zip)

BRITISH COLUMBIA, CANADA

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/07/2026
3. Issuer Name and Ticker or Trading Symbol
Nu-Med Plus, Inc. [ NUMD ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
SVP and Chief Geologist
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock0D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Fred Tejada08/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)